Kyoto, Japan

Liying Yang


 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:

goldMedal2 out of 10 
 
Stella Pharma Corporation
 patents
silverMedal3 out of 832,718 
Other
 patents
where one patent can have more than one assignee

Years Active: 2013-2015

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Liying Yang: Innovator in Anticancer Peptide Development

Introduction

Liying Yang is a prominent inventor based in Kyoto, Japan. She has made significant contributions to the field of cancer treatment through her innovative work on chimeric peptides. With a total of 3 patents, her research focuses on developing substances that can effectively target cancer cells while minimizing side effects on normal cells.

Latest Patents

Liying Yang's latest patents include groundbreaking inventions in the realm of anticancer agents. One of her notable patents is for selective anticancer chimeric peptides that bind to the transferrin receptor. This invention aims to provide a substance that has intracellular stability and can evade side effects associated with normal cells. The chimeric peptide developed by Yang targets cancer cells that overexpress EGFR, utilizing a binding peptide sequence and a lytic peptide sequence to achieve its objectives.

Another significant patent involves selective anticancer chimeric peptides that bind to the neuropilin receptor. Similar to her previous work, this invention also focuses on creating a substance that can serve as an anticancer agent with the ability to avoid side effects. By employing a chimeric peptide that includes an EGF receptor-binding peptide and a cytotoxic peptide, Yang addresses the challenges faced in cancer treatment.

Career Highlights

Throughout her career, Liying Yang has worked with various organizations, including Stella Pharma Corporation. Her work has been instrumental in advancing the understanding and application of chimeric peptides in cancer therapy.

Collaborations

Liying Yang has collaborated with notable professionals in her field, including Koji Kawakami and Masayuki Kohno. These collaborations have further enriched her research and contributed to the development of innovative solutions in cancer treatment.

Conclusion

Liying Yang's contributions to the field of anticancer research through her innovative chimeric peptides highlight her role as a leading inventor. Her work continues to pave the way for advancements in cancer therapy, showcasing the potential of targeted treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…